Patents by Inventor Saul Schaefer

Saul Schaefer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11647978
    Abstract: The present disclosure describes systems, methods, and devices to infer changes in pulmonary artery pressure in a subject using Doppler radar. A portable, non-invasive device for non-invasively measuring right ventricular cardiac motion that can be used in a subject's home can infer pulmonary artery pressure changes to increase patient compliance and mitigate the likelihood of heart decompensation. A mobile pulmonary artery pressure monitor can be especially useful to patients with congestive heart failure who are elderly, incapacitated, or do not have easy access to a clinic, doctor's office, or hospital.
    Type: Grant
    Filed: November 24, 2020
    Date of Patent: May 16, 2023
    Assignee: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
    Inventors: Xiaomeng Gao, Xiaonan Jiang, Xiaoguang Liu, Dennis Matthews, Saul Schaefer
  • Publication number: 20210212657
    Abstract: The present disclosure describes systems, methods, and devices to infer changes in pulmonary artery pressure in a subject using Doppler radar. A portable, non-invasive device for non-invasively measuring right ventricular cardiac motion that can be used in a subject's home can infer pulmonary artery pressure changes to increase patient compliance and mitigate the likelihood of heart decompensation. A mobile pulmonary artery pressure monitor can be especially useful to patients with congestive heart failure who are elderly, incapacitated, or do not have easy access to a clinic, doctor's office, or hospital.
    Type: Application
    Filed: November 24, 2020
    Publication date: July 15, 2021
    Inventors: Xiaomeng GAO, Xiaonan JIANG, Xiaoguang LIU, Dennis MATTHEWS, Saul SCHAEFER
  • Publication number: 20120046251
    Abstract: The invention discloses methods of using cis-epoxyeicosantrienoic acids (“EETs”), inhibitors of soluble epoxide hydrolase (“sEH”), or a combination of an EET and an inhibitor of sEH, to reduce or prevent niacin-induced cutaneous vasodilation (“flushing”) in subjects suffering from this undesirable side effect of receiving therapeutic amounts of niacin.
    Type: Application
    Filed: April 5, 2010
    Publication date: February 23, 2012
    Applicant: The Regents of the University of California
    Inventors: Saul Schaefer, Bruce D. Hammock, Ahmet Bora Inceoglu
  • Patent number: 6034109
    Abstract: A therapeutic and prophylactic method for protection of heart or heart tissue by limiting metabolic and ionic abnormalities developed during, following or associated with ischemia by administering to a subject in need either a compound which reduces NADH/NAD.sup.+ ratio and stimulates glycolysis to produce ATP or a compound which inhibits cotransporter of sodium-potassium-chloride.
    Type: Grant
    Filed: July 17, 1998
    Date of Patent: March 7, 2000
    Assignee: The Regents of the University of California
    Inventors: Ravichandran Ramasamy, Saul Schaefer
  • Patent number: 5834466
    Abstract: A therapeutic and prophylactic method for protection of heart or heart tissue by limiting metabolic and ionic abnormalities developed during, following or associated with ischemia by administering to a subject in need either a compound which reduces NADH/NAD.sup.+ ratio and stimulates glycolysis to produce ATP or a compound which inhibits cotransporter of sodium-potassium-chloride.
    Type: Grant
    Filed: December 19, 1995
    Date of Patent: November 10, 1998
    Assignee: The Regents of the University of California
    Inventors: Ravichandran Ramasamy, Saul Schaefer